Morpholine → HCID 10381327, compound
Reaction equation
[NH2:1][C:2]1[C:10]2[C:9]([C:11]([OH:13])=O)=[CH:8][C:7]([CH3:14])=[N:6][C:5]=2[S:4][C:3]=1[C:15](=[O:17])[NH2:16].[NH:18]1[CH2:23][CH2:22][O:21][CH2:20][CH2:19]1.C1CN([P+](ON2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F>CN(C=O)C.O>[NH2:1][C:2]1[C:10]2[C:5](=[N:6][C:7]([CH3:14])=[CH:8][C:9]=2[C:11]([N:18]2[CH2:23][CH2:22][O:21][CH2:20][CH2:19]2)=[O:13])[S:4][C:3]=1[C:15]([NH2:16])=[O:17]Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 3-amino-2-carbamoyl-6-methyl-thieno[2,3-b]pyridine-4-carboxylic acid (see Example 10) (0.5 g, 2.0 mmol), morpholine (0.87 g, 10 mmol) and PyBop (0.88 g, 2.0 mmol) in DMF (10 mL) was stirred at room temperature overnight. It was diluted with water and extracted with methylene chloride (50 mL). Concentration of the organic phase the title compound as an orange solid (0.45 g, 70.3%).
Workup
- extractionextracted with methylene chloride (50 mL)
Sources & evidence
- ORD record
- ord-423b0babb18c4718aaf7c52a91e0f840
- Source dataset
- uspto-grants-2008_07
- Patent number
- US07405225B2
Reaction notes
Loading…